STOCK TITAN

Proposed sale of 2,000 United Therapeutics shares (UTHR) via option exercise

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

United Therapeutics reported a Form 144 notice proposing the sale of 2,000 common shares. The filing lists the proposed sale date as 03/04/2026, arising from a stock option exercise with proceeds to be received in cash. The record shows a prior sale of 910 shares on 12/18/2025 for $455,533.17.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does UTHR's Form 144 report?

It reports a proposed sale of 2,000 common shares on 03/04/2026. The filing states the sale arises from a stock option exercise and that proceeds will be received in cash.

Who is the reported selling party in the UTHR Form 144?

The filing lists Tommy Thompson at the provided address as the filer. Broker information names Morgan Stanley Smith Barney LLC, with execution details and the 03/04/2026 sale date shown.

How were the shares to be sold and when is the sale dated?

The 2,000 shares are tied to a stock option exercise and to be sold for cash. The proposed sale date in the filing is 03/04/2026.

Does the filing show recent prior sales by the same filer?

Yes — it discloses a prior sale of 910 common shares on 12/18/2025. That past sale is shown with a value of $455,533.17 in the excerpt.

What broker is listed for the proposed UTHR sale?

Morgan Stanley Smith Barney LLC is named in the securities and broker lines. The broker address and related execution details appear in the filing excerpt.
United Therapeutics Corp.

NASDAQ:UTHR

UTHR Rankings

UTHR Latest News

UTHR Latest SEC Filings

UTHR Stock Data

21.85B
42.11M
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States
SILVER SPRING